Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Fibroblast growth factor receptor 2 mutations in Beare–Stevenson cutis gyrata syndrome

Abstract

Beare-Stevenson cutis gyrata syndrome (MIM 123790) is an autosomal dominant condition characterized by the furrowed skin disorder of cutis gyrata, acanthosis nigricans, craniosynostosis, craniofacial dysmorphism, digital anomalies, umbilical and anogenital abnormalities and early death1–5. Many of these features are characteristic of some of the autosomal dominant craniosynostotic syndromes6. Mutations in Crouzon, Jackson-Weiss, Pfeiffer and Apert syndromes have been reported in the FGFR2 extracellular domain7–14. In Crouzon syndrome patients with acanthosis nigricans, a recurrent mutation occurs in the transmembrane domain of FGFR315. We now describe the detection of FGFR2 mutations in the Beare-Stevenson cutis gyrata syndrome. In three sporadic cases, a novel missense mutation was found causing an amino acid to be replaced by a cysteine; two had the identical Tyr375Cys mutation in the transmembrane domain and one had a Ser372Cys mutation in the carboxyl-terminal end of the linker region between the immunoglobulin III-like (IgIII) and transmembrane domains. In two patients, neither of these mutations were found suggesting further genetic heterogeneity.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Beare, J.M., Dodge, J.A. & Nevin, N.C. Cutis gyratum, acanthosis nigricans and other congenital anomalies: a new syndrome. Br. J. Derm. 8, 241–247 (1969).

    Article  Google Scholar 

  2. Stevenson, R.E., Feriauto, G.J. & Taylor, H.A. Cutis gyratum and acanthosis nigricans associated with other anomalies: a distinctive syndrome. J. Pediatr. 92, 950–952 (1978).

    Article  CAS  PubMed  Google Scholar 

  3. Hall, B.D., Cadle, R.G., Golabi, M., Morris, C.A. & Cohen, M.M. Jr. . Beare-Stevenson cutis gyrata syndrome. Am. J. Med. Genet. 44, 82–89 (1992).

    Article  CAS  PubMed  Google Scholar 

  4. Andrews, J.M., Martins, D.M.F.S., Ramos, R.R. & Ferreira, L.M. A severe case of Beare-Stevenson syndrome and associated congenital deformities. Brit J. Plast Surg. 46, 443–446 (1993).

    Article  CAS  PubMed  Google Scholar 

  5. Bratanic, B., Praprotnik, M. & Novosel-Sever, M. Congenital craniofacial dysostosis and cutis gyratum: the Beare-Stevenson syndrome. Eur. J. Pediatr. 153, 184–186 (1994).

    Article  CAS  PubMed  Google Scholar 

  6. Cohen, M.M., Update 1987. Am. J. Med. Genet. 4, 99–148 (1988).

    Article  Google Scholar 

  7. Reardon, W., Winter, R.M., Rutland, P., Pulleyn, L.J., Jones, B.M. & Malcolm, S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet. 8, 98–103 (1994).

    Article  CAS  PubMed  Google Scholar 

  8. Jabs, E.W. et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genet. 8, 275–279 (1994).

    Article  CAS  PubMed  Google Scholar 

  9. Schell, U. et al. Mutations in FGFR1 and FGFR2 cause both familial and sporadic Pfeiffer syndrome. Hum. Molec. Genet. 4, 323–328 (1995).

    Article  CAS  PubMed  Google Scholar 

  10. Park, W.-J. et al. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum. Molec. Genet. 4, 1229–1233 (1995).

    Article  CAS  PubMed  Google Scholar 

  11. Gorry, M.C. et al. Crouzon Syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum. Molec. Genet. 4, 1387–1390 (1995).

    Article  CAS  PubMed  Google Scholar 

  12. Meyers, G.A. et al. FGFR2 exon Ilia and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am. J. Hum. Genet. 5, 491–498 (1996).

    Google Scholar 

  13. Wilkie, A.O.M. et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet. 9, 165–172 (1995).

    Article  CAS  PubMed  Google Scholar 

  14. Park, W.-J. et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am. J. Hum. Genet. 57, 321–328 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Meyers, G.A., Orlow, S.J., Munro, I.R., Przylepa, K.A. & Jabs, E.W. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet. 11, 462–464 (1995).

    Article  CAS  PubMed  Google Scholar 

  16. Dionne, C.A. et al. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 8, 2685–2692 (1990).

    Article  Google Scholar 

  17. Orr-Urtreger, A. et al. Developmental localization of splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol. 158, 475–486 (1993).

    Article  CAS  PubMed  Google Scholar 

  18. Werner, S. et al. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266(5186),819–822 (1994).

    Article  CAS  PubMed  Google Scholar 

  19. Bias, W.B., Zachary, A.A. & Rosner, G.L. Genetic and statistical principles of paternity determination. in Manual of Clinical Laboratory Immunology, 4th Edn.(eds. N.R. Rose, E.C. de Macario, J.L Fahey, H. Friedman &G.M. Penn) 136, 901–912 (Am. Soc. Microbiol. Chem., Washington DC, 1992).

    Google Scholar 

  20. Bellot, F., Crumley, G., Kaplow, J.M., Schlessinger, J., Jaye, M. & CA Ligand-induced transphosphorylation between different FGF receptors. EMBO J. 10, 2849–2854 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ornitz, D. & Leder, P. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267, 16305–16311 (1992).

    CAS  PubMed  Google Scholar 

  22. Miki, T. et al. Determination of ligand binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA 89, 249–250 (1992).

    Article  Google Scholar 

  23. Peters, K., Ornitz, D., Werner, S. & L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155, 423–430 (1993).

    Article  CAS  PubMed  Google Scholar 

  24. Neilson, K.M. & Friesel, R.E. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270, 26037–26040 (1995).

    Article  CAS  PubMed  Google Scholar 

  25. Rousseau, F. et al. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum. Mol. Genet. 5, 509–612 (1996).

    Article  CAS  PubMed  Google Scholar 

  26. Jen, J. et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. NEJM 331, 213–221 (1994).

    Article  CAS  PubMed  Google Scholar 

  27. Olerup, O. & Zetterquist, H. HLA-DR by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 39, 225–235 (1992).

    Article  CAS  PubMed  Google Scholar 

  28. Superti-Furga, A. et al. A glycine-375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur. J. Pediat. 154, 215–219 (1995).

    Article  CAS  Google Scholar 

  29. Shiang, R. et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 336–342 (1994).

    Article  Google Scholar 

  30. Tavormina, P.L et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet. 9, 321–328 (1995).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ethylin Wang Jabs.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Przylepa, K., Paznekas, W., Zhang, M. et al. Fibroblast growth factor receptor 2 mutations in Beare–Stevenson cutis gyrata syndrome. Nat Genet 13, 492–494 (1996). https://doi.org/10.1038/ng0896-492

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0896-492

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing